Drug Profile
Axitirome
Alternative Names: CGP 26214; CGS 26214Latest Information Update: 30 Apr 2003
Price :
$50
*
At a glance
- Originator Novartis
- Class Antihyperlipidaemics
- Mechanism of Action LDL receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hyperlipidaemia